| Dr Frank S Ellis, MD | |
|
609 Mcfarland St, Morristown, TN 37814-3976 | |
| (423) 714-0714 | |
| (423) 587-3799 |
| Full Name | Dr Frank S Ellis |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 40 Years |
| Location | 609 Mcfarland St, Morristown, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275531980 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 16327 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morristown Hamblen Hospital Association | Morristown, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthstar Physicians, P.c. | 5890690978 | 94 |
News Archive
23andMe, Inc., the leading personal genetics company, today announced the results of a genome-wide association study (GWAS) identifying genetic variants associated with being a morning person.
Royal Philips, a leader in health technology, today announced the global launch of Azurion, its next generation image-guided therapy (IGT) platform that integrates advanced interventional tools into one clinician platform. Combining advancements in vascular surgery, interventional cardiology, oncology and neuroradiology, Azurion provides procedure cards that allow clinicians to pre-program routine tasks and user preferences while state-of-the-art ergonomic design and an intuitive user interface lets clinicians swiftly and confidently perform a wide range of routine and complex procedures in the interventional lab.
At the world's largest conference on infectious diseases – the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) which opens today – a special Symposium on NMD-1 (New Delhi metallo-beta-lactamase) will focus on the implications of the increasing detection of this gene, which makes bacteria highly resistant to almost all known antibiotics. This is part of an alarming trend of antibiotic resistance that threatens to turn back the clock on years of progress following the discovery of antimicrobials, which revolutionised human health globally.
According to new findings by Yale Cancer Center scientists, higher levels of genetic mutations in a tumor biopsy are linked to improved clinical outcomes in patients using pembrolizumab (Keytruda) to treat non-small cell lung cancer (NSCLC).
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).
› Verified 2 days ago
| Entity Name | Healthstar Physicians, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184610248 PECOS PAC ID: 5890690978 Enrollment ID: O20031203000021 |
News Archive
23andMe, Inc., the leading personal genetics company, today announced the results of a genome-wide association study (GWAS) identifying genetic variants associated with being a morning person.
Royal Philips, a leader in health technology, today announced the global launch of Azurion, its next generation image-guided therapy (IGT) platform that integrates advanced interventional tools into one clinician platform. Combining advancements in vascular surgery, interventional cardiology, oncology and neuroradiology, Azurion provides procedure cards that allow clinicians to pre-program routine tasks and user preferences while state-of-the-art ergonomic design and an intuitive user interface lets clinicians swiftly and confidently perform a wide range of routine and complex procedures in the interventional lab.
At the world's largest conference on infectious diseases – the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) which opens today – a special Symposium on NMD-1 (New Delhi metallo-beta-lactamase) will focus on the implications of the increasing detection of this gene, which makes bacteria highly resistant to almost all known antibiotics. This is part of an alarming trend of antibiotic resistance that threatens to turn back the clock on years of progress following the discovery of antimicrobials, which revolutionised human health globally.
According to new findings by Yale Cancer Center scientists, higher levels of genetic mutations in a tumor biopsy are linked to improved clinical outcomes in patients using pembrolizumab (Keytruda) to treat non-small cell lung cancer (NSCLC).
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).
› Verified 2 days ago
| Entity Name | Covenant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457302010 PECOS PAC ID: 2860305463 Enrollment ID: O20060719000030 |
News Archive
23andMe, Inc., the leading personal genetics company, today announced the results of a genome-wide association study (GWAS) identifying genetic variants associated with being a morning person.
Royal Philips, a leader in health technology, today announced the global launch of Azurion, its next generation image-guided therapy (IGT) platform that integrates advanced interventional tools into one clinician platform. Combining advancements in vascular surgery, interventional cardiology, oncology and neuroradiology, Azurion provides procedure cards that allow clinicians to pre-program routine tasks and user preferences while state-of-the-art ergonomic design and an intuitive user interface lets clinicians swiftly and confidently perform a wide range of routine and complex procedures in the interventional lab.
At the world's largest conference on infectious diseases – the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) which opens today – a special Symposium on NMD-1 (New Delhi metallo-beta-lactamase) will focus on the implications of the increasing detection of this gene, which makes bacteria highly resistant to almost all known antibiotics. This is part of an alarming trend of antibiotic resistance that threatens to turn back the clock on years of progress following the discovery of antimicrobials, which revolutionised human health globally.
According to new findings by Yale Cancer Center scientists, higher levels of genetic mutations in a tumor biopsy are linked to improved clinical outcomes in patients using pembrolizumab (Keytruda) to treat non-small cell lung cancer (NSCLC).
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Frank S Ellis, MD 609 Mcfarland St, Morristown, TN 37814-3976 Ph: (423) 714-0714 | Dr Frank S Ellis, MD 609 Mcfarland St, Morristown, TN 37814-3976 Ph: (423) 714-0714 |
News Archive
23andMe, Inc., the leading personal genetics company, today announced the results of a genome-wide association study (GWAS) identifying genetic variants associated with being a morning person.
Royal Philips, a leader in health technology, today announced the global launch of Azurion, its next generation image-guided therapy (IGT) platform that integrates advanced interventional tools into one clinician platform. Combining advancements in vascular surgery, interventional cardiology, oncology and neuroradiology, Azurion provides procedure cards that allow clinicians to pre-program routine tasks and user preferences while state-of-the-art ergonomic design and an intuitive user interface lets clinicians swiftly and confidently perform a wide range of routine and complex procedures in the interventional lab.
At the world's largest conference on infectious diseases – the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) which opens today – a special Symposium on NMD-1 (New Delhi metallo-beta-lactamase) will focus on the implications of the increasing detection of this gene, which makes bacteria highly resistant to almost all known antibiotics. This is part of an alarming trend of antibiotic resistance that threatens to turn back the clock on years of progress following the discovery of antimicrobials, which revolutionised human health globally.
According to new findings by Yale Cancer Center scientists, higher levels of genetic mutations in a tumor biopsy are linked to improved clinical outcomes in patients using pembrolizumab (Keytruda) to treat non-small cell lung cancer (NSCLC).
VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced the results of the Oncologic Drugs Advisory Committee (ODAC) Meeting at which data for its lead oncology therapeutic Onrigin(TM)(laromustine) Injection were presented for the indication of remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML).
› Verified 2 days ago
Dr. Marilyn Schulz Gordon, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 856 W 4th North St, Morristown, TN 37814 Phone: 423-587-0067 Fax: 423-581-5882 | |
Helen Sandland, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 619 W 7th North St, Ste. F, Morristown, TN 37814 Phone: 423-587-9948 Fax: 423-587-9828 | |
Dr. Peter L Clark, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 609 Mcfarland St, Morristown, TN 37814 Phone: 423-714-0714 Fax: 423-587-3799 | |
Kim Cheree Brooks, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1621 W Morris Blvd Ste A, Morristown, TN 37813 Phone: 423-492-7100 Fax: 423-492-8801 | |
Kim A Collinson, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1907 W Morris Blvd Ste A300, Morristown, TN 37813 Phone: 423-587-9949 Fax: 423-587-9828 | |
Craig Cole Anderson, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 305 N Bellwood Rd, Morristown, TN 37814 Phone: 423-587-8200 Fax: 423-587-8204 |